Loading...
Loading...
Among the 7 tracked institutional investors we monitor, CRNX (CRINETICS PHARMACEUTICALS IN) is held with a combined value of $1.49B across 38,537,131 shares. The largest holder is FMR LLC with a position worth $572.40M (0.03% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$1.49B
Total Shares Held
38,537,131
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $572.40M | 0.03% | +10.3% |
| 2 | VANGUARD GROUP INC | $425.26M | 0.01% | New |
| 3 | BlackRock, Inc. | $307.95M | 0.01% | +6.1% |
| 4 | STATE STREET CORP | $87.28M | 0.00% | +11.2% |
| 5 | BAKER BROS. ADVISORS LP | $85.41M | 0.49% | +42.6% |
| 6 | CITADEL ADVISORS LLC | $12.57M | 0.00% | +21.7% |
| 7 | MILLENNIUM MANAGEMENT LLC | $2.27M | 0.00% | -79.2% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of CRNX with a position worth $572.40M, representing 0.03% of their portfolio. In total, 7 institutional investors hold CRNX with a combined value of $1.49B.
In the most recent quarter, 1 fund opened a new position in CRNX. Additionally, 5 increased their holdings and 1 reduced their positions.
Institutional investors hold $1.49B worth of CRNX stock across 7 positions. The largest institutional holder is FMR LLC with $572.40M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CRNX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CRNX positions.